Interaction of A3 adenosine receptor ligands with the human multidrug transporter ABCG2

Eur J Med Chem. 2022 Mar 5:231:114103. doi: 10.1016/j.ejmech.2022.114103. Epub 2022 Jan 10.

Abstract

Various adenosine receptor nucleoside-like ligands were found to modulate ATP hydrolysis by the multidrug transporter ABCG2. Both ribose-containing and rigidified (N)-methanocarba nucleosides (C2-, N6- and 5'-modified), as well as adenines (C2-, N6-, and deaza modified), were included. 57 compounds out of 63 tested either stimulated (50) or inhibited (7) basal ATPase activity. Structure-activity analysis showed a separation of adenosine receptor and ABCG2 activities. The 7-deaza modification had favorable effects in both (N)-methanocarba nucleosides and adenines. Adenine 37c (MRS7608) and (N)-methanocarba 7-deaza-5'-ethyl ester 60 (MRS7343) were found to be potent stimulators of ABCG2 ATPase activity with EC50 values of 13.2 ± 1.7 and 13.2 ± 2.2 nM, respectively. Both had affinity in the micromolar range for A3 adenosine receptor and lacked the 5'-amide agonist-enabling group (37c was reported as a weak A3 antagonist, Ki 6.82 μM). Compound 60 significantly inhibited ABCG2 substrate transport (IC50 0.44 μM). Docking simulations predicted the interaction of 60 with 21 residues in the drug-binding pocket of ABCG2.

Keywords: A(3) adenosine receptor; ABC transporter; ABCG2; ATP hydrolysis; Drug transport; Multidrug resistance.

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily G, Member 2
  • Humans
  • Ligands
  • Neoplasm Proteins
  • Nucleosides* / chemistry
  • Protein Binding
  • Receptor, Adenosine A3 / metabolism
  • Receptors, Purinergic P1
  • Ribose* / chemistry

Substances

  • ABCG2 protein, human
  • ATP Binding Cassette Transporter, Subfamily G, Member 2
  • Ligands
  • Neoplasm Proteins
  • Nucleosides
  • Receptor, Adenosine A3
  • Receptors, Purinergic P1
  • Ribose